EP1229795A4 - Human chemokine beta-13 - Google Patents

Human chemokine beta-13

Info

Publication number
EP1229795A4
EP1229795A4 EP00978340A EP00978340A EP1229795A4 EP 1229795 A4 EP1229795 A4 EP 1229795A4 EP 00978340 A EP00978340 A EP 00978340A EP 00978340 A EP00978340 A EP 00978340A EP 1229795 A4 EP1229795 A4 EP 1229795A4
Authority
EP
European Patent Office
Prior art keywords
human chemokine
chemokine beta
beta
human
chemokine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00978340A
Other languages
German (de)
French (fr)
Other versions
EP1229795A2 (en
Inventor
Stephen Ullrich
George Seibel
Haodong Li
Francis W Luscinskas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Human Genome Sciences Inc
SmithKline Beecham Corp
Original Assignee
Brigham and Womens Hospital Inc
Human Genome Sciences Inc
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc, Human Genome Sciences Inc, SmithKline Beecham Corp filed Critical Brigham and Womens Hospital Inc
Publication of EP1229795A2 publication Critical patent/EP1229795A2/en
Publication of EP1229795A4 publication Critical patent/EP1229795A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP00978340A 1999-11-03 2000-11-02 Human chemokine beta-13 Withdrawn EP1229795A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43276899A 1999-11-03 1999-11-03
US432768 1999-11-03
PCT/US2000/030237 WO2001032128A2 (en) 1999-11-03 2000-11-02 Human chemokine beta-13

Publications (2)

Publication Number Publication Date
EP1229795A2 EP1229795A2 (en) 2002-08-14
EP1229795A4 true EP1229795A4 (en) 2004-07-28

Family

ID=23717510

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00978340A Withdrawn EP1229795A4 (en) 1999-11-03 2000-11-02 Human chemokine beta-13

Country Status (5)

Country Link
EP (1) EP1229795A4 (en)
JP (1) JP2003514517A (en)
AU (1) AU1581301A (en)
CA (1) CA2387808A1 (en)
WO (1) WO2001032128A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737513B1 (en) 1996-06-07 2004-05-18 Icos Corporation Macrophage derived chemokine (MDC) and chemokine analogs and assay to identify modulators of MDC activity, and therapeutic uses for same
US7018627B1 (en) 1995-06-07 2006-03-28 Icos Corporation Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances, and uses thereof
US20060228331A1 (en) 2003-10-10 2006-10-12 Novo Nordisk A/S IL-21 Derivatives and variants
MXPA06004199A (en) * 2003-10-17 2006-06-28 Novo Nordisk As Combination therapy.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997019696A1 (en) * 1995-11-30 1997-06-05 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health, Office Of Technology Transfer C-c chemokines that inhibit retrovirus infection
WO1998024908A1 (en) * 1996-12-05 1998-06-11 Human Genome Sciences, Inc. Human chemokine beta-13

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039521A1 (en) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Human chemokine beta-13

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997019696A1 (en) * 1995-11-30 1997-06-05 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health, Office Of Technology Transfer C-c chemokines that inhibit retrovirus infection
WO1998024908A1 (en) * 1996-12-05 1998-06-11 Human Genome Sciences, Inc. Human chemokine beta-13

Also Published As

Publication number Publication date
JP2003514517A (en) 2003-04-22
WO2001032128A2 (en) 2001-05-10
AU1581301A (en) 2001-05-14
CA2387808A1 (en) 2001-05-10
WO2001032128A3 (en) 2001-11-08
EP1229795A2 (en) 2002-08-14
WO2001032128A9 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
GB9915414D0 (en) Medical use
GB9913536D0 (en) Use
IL145995A0 (en) Use
AU141983S (en) Chair
EP1180338A4 (en) Chair
AU141984S (en) Chair
PL353215A1 (en) Phospholipin gel
GB9907965D0 (en) Medical use
EP1229795A4 (en) Human chemokine beta-13
EP1194439A4 (en) Human eag2
GB9907105D0 (en) Chair
GB9919971D0 (en) Use
TW387258U (en) Medical air-sucker
GB9923185D0 (en) Tip-seat chair
CA86702S (en) Chair
CA86999S (en) Chair
CA87400S (en) Chair
CA87673S (en) Chair
CA87729S (en) Chair
CA86689S (en) Chair
CA86690S (en) Chair
CA86691S (en) Chair
CA86703S (en) Chair
CA86704S (en) Chair
CA87004S (en) Chair

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020603

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SMITHKLINE BEECHAM CORPORATION

Owner name: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

Owner name: HUMAN GENOME SCIENCES, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20040615

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12Q 1/68 B

Ipc: 7G 01N 33/68 B

Ipc: 7A 61K 48/00 B

Ipc: 7A 61K 39/395 B

Ipc: 7A 61K 38/19 B

Ipc: 7A 61K 31/713 B

Ipc: 7A 61K 31/7088 B

Ipc: 7A 01K 67/027 B

Ipc: 7C 07K 16/24 B

Ipc: 7C 07K 14/52 B

Ipc: 7C 12N 5/10 B

Ipc: 7C 12N 1/21 B

Ipc: 7C 12N 15/63 B

Ipc: 7C 12N 15/62 B

Ipc: 7C 12N 15/19 A

17Q First examination report despatched

Effective date: 20050202

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050614